Sai Life Sciences
SAILIFEHyderabad, India· Est.
India's leading CDMO delivering integrated drug development and manufacturing services across therapeutic areas.
Is this your company? Claim your profile to update info and connect with investors.
Claim profileAI Company Overview
India's leading CDMO delivering integrated drug development and manufacturing services across therapeutic areas.
OncologyCardiovascularCentral Nervous SystemInfectious DiseasesImmunology
Technology Platform
An integrated end‑to‑end drug development platform combining high‑throughput chemistry, advanced analytical suites, and modular GMP manufacturing for small molecules and biologics.
Opportunities
Expanding biologics and cell‑therapy manufacturing capacity and targeting high‑growth markets in Europe and the US will drive revenue acceleration.
Risk Factors
Intense competition from global CDMOs, regulatory compliance challenges, and potential capacity under‑utilization could impact margins.
Competitive Landscape
Competes with Indian CDMOs like Suven and Jubilant Biosys; differentiation lies in its integrated platform, large‑scale GMP facilities, and cost‑effective Indian base.